Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smaller scars for breast reconstruction: endoscopic technique put to the test

NCT ID NCT07691294

Disease control Sponsor: Kasr El Aini Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests a surgical technique for breast reconstruction that uses a tiny camera (endoscope) to help the surgeon harvest muscle and skin from the back through a smaller cut. The goal is to rebuild the breast after cancer or burn injuries while leaving a less noticeable scar on the back. The study includes 15 women aged 18 to 65 who need a skin paddle no larger than 6 cm. Researchers will check if the procedure is feasible, safe, and leads to good cosmetic results and patient satisfaction over one year.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Endoscopic-assisted latissimus dorsi musculocutaneous flap harvest
What this could lead to
If successful, this technique could offer women a breast reconstruction option with smaller scars and less donor-site damage, while still achieving good cosmetic results.
What could go wrong
This is a small, early-stage study with only 15 participants, so results may not apply to everyone. The procedure may not work for larger skin paddles or could have complications like flap failure or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

15 people

The number who actually took part.

Started

Jan 2023

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients aged 18 to 65 years. * Patients with post-oncologic or post-burn breast deformities requiring autologous breast reconstruction. * Patients requiring reconstruction with a latissimus dorsi musculocutaneous flap incorporating a skin paddle measuring ≤6 cm in its greatest dimension. * Defects considered unsuitable for correction with local tissue rearrangement. * Intact latissimus dorsi muscle and thoracodorsal vascular pedicle. * Ability to provide written informed consent and comply with the study follow-up schedule. Exclusion Criteria: * Age younger than 18 years or older than 65 years. * Body mass index (BMI) \>35 kg/m². * Uncontrolled medical comorbidities or immunosuppressive conditions. * Absence of a skin defect requiring reconstruction. * Cutaneous defects requiring a skin paddle \>6 cm in its greatest dimension. * Inadequate oncologic control or evidence of active disease. * Ongoing adjuvant chemotherapy or radiotherapy at the time of reconstruction. * Previous thoracic surgery or trauma compromising the latissimus dorsi muscle or thoracodorsal vascular pedicle. * Inability or unwillingness to comply with study follow-up.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acquired breast deformity are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acquired breast deformity Breast cancer Post burn breast deformities

Contacts and locations

Locations

  • Kasr El Aini Hospital

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.